Biogen Accounts Payable from 2010 to 2024
| BIIB Stock | USD 193.18 0.93 0.48% |
Accounts Payable | First Reported 1989-12-31 | Previous Quarter 440.1 M | Current Value 403.3 M | Quarterly Volatility 152.9 M |
Check Biogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biogen main balance sheet or income statement drivers, such as Depreciation And Amortization of 256.8 M, Interest Expense of 259.2 M or Selling General Administrative of 2.6 B, as well as many exotic indicators such as Price To Sales Ratio of 3.62, Dividend Yield of 0.0022 or PTB Ratio of 2.4. Biogen financial statements analysis is a perfect complement when working with Biogen Valuation or Volatility modules.
Biogen | Accounts Payable |
Latest Biogen's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Biogen Inc over the last few years. An accounting item on the balance sheet that represents Biogen obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Biogen Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Biogen's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biogen's overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
Biogen Accounts Payable Regression Statistics
| Arithmetic Mean | 336,513,533 | |
| Geometric Mean | 238,228,464 | |
| Coefficient Of Variation | 46.41 | |
| Mean Deviation | 128,940,898 | |
| Median | 370,500,000 | |
| Standard Deviation | 156,184,858 | |
| Sample Variance | 24393.7T | |
| Range | 587.4M | |
| R-Value | 0.87 | |
| Mean Square Error | 6597.9T | |
| R-Squared | 0.75 | |
| Significance | 0.000031 | |
| Slope | 30,221,736 | |
| Total Sum of Squares | 341511.9T |
Biogen Accounts Payable History
About Biogen Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Biogen income statement, its balance sheet, and the statement of cash flows. Biogen investors use historical funamental indicators, such as Biogen's Accounts Payable, to determine how well the company is positioned to perform in the future. Although Biogen investors may use each financial statement separately, they are all related. The changes in Biogen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biogen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Biogen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Biogen. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 403.3 M | 423.5 M |
Pair Trading with Biogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.Moving together with Biogen Stock
| 0.71 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Biogen Stock
| 0.83 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.78 | OPT | Opthea | PairCorr |
| 0.77 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
| 0.76 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.61 | AVTE | Aerovate Therapeutics Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Biogen Correlation against competitors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 7.96 | Revenue Per Share 67.972 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0458 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.